29 results
S-3ASR
EX-1.2
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
in the Registration Statement and Prospectus satisfies the independence standards established by Nasdaq and, with respect to members of the Company’s audit … committee, the enhanced independence standards contained in Rule 10A-3(b)(1) promulgated by the Commission under the Exchange Act.
(aaa) Neither
8-K
EX-3.1
ZNTL
Zentalis Pharmaceuticals Inc
15 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:12pm
of record therefor) with respect to the background, qualifications, stock ownership and independence of such proposed nominee and (ii) a written
DEFA14A
ZNTL
Zentalis Pharmaceuticals Inc
10 May 23
Additional proxy soliciting materials
7:08am
as an independent director under Nasdaq’s heightened independence standards for members of a compensation committee and as a “non-employee director” as defined
PRE 14A
zcfab4q vmc3rhk
18 Apr 23
Preliminary proxy
4:30pm
S-3ASR
EX-1.2
aj65qyg8l3s
4 May 21
Automatic shelf registration
5:29pm
S-3
EX-1.2
4qd3os54
4 May 21
Shelf registration
12:00am
DEF 14A
rwcq1jjq802111 ol1
23 Apr 21
Definitive proxy
4:05pm
10-K
qtdtpknh
25 Mar 21
Annual report
7:17am
8-K
EX-3.1
gzgm0q
19 Mar 21
Amendments to Articles of Incorporation or Bylaws
4:08pm
8-K
EX-10.1
cgj 2w0tl4
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
424B4
9j5 ujm5q9noy
31 Jul 20
Prospectus supplement with pricing info
12:00am
DRS
EX-4.1
9wefdf8pfhis6zuxfn2p
10 Jul 20
Draft registration statement
12:00am